Inchauspe, G. (Geneviese)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
2 results
Search Results
Now showing 1 - 2 of 2
- Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting(Oxford University Press, 2005) Paranhos-Baccala, G. (Glaucia); Berland, J.L. (Jean-Luc); Rollier, C.S. (Christine S.); Barnfield, C. (Christina); Verschoor, E.J. (Ernst J.); Verstrepen, B.E. (Babs E.); Liljestrom, P. (Peter); Himoudi, N. (Nourredine); Ruiz, J. (Juan); Heeney, J.L. (Jonathan L.); Drexhage, J.A.R. (Joost A.R.); Inchauspe, G. (Geneviese); Lasarte, J.J. (Juan José)BACKGROUND: Preventive and therapeutic vaccine strategies aimed at controlling hepatitis C virus (HCV) infection should mimic the immune responses observed in patients who control or clear HCV, specifically T helper (Th) type 1 and CD8+ cell responses to multiple antigens, including nonstructural protein (NS) 3. Given the experience with human immunodeficiency virus, the best candidates for this are based on DNA prime, pox, or adenovirus boost regimens. METHODS: In rhesus macaques, we compared NS3-expressing DNA prime and adenovirus boost strategy with 2 alternative priming approaches aimed at modifying Th1 and CD8+ responses: DNA adjuvanted with interleukin (IL)-2- and -12-encoding plasmids or Semliki Forest virus (SFV). RESULTS: All prime-boost regimens elicited NS3-specific B and T cell responses in rhesus macaques, including CD8+ responses. SFV priming induced higher lymphoproliferation and longer Th1 memory responses. The use of IL-2- and IL-12-expressing vectors resulted in reduced Th2 and antibody responses, which led to increased Th1 skewing but not to an increase in the magnitude of the IFN- gamma and CD8+ responses. CONCLUSIONS: All strategies induced Th1 cellular responses to HCV NS3, with fine modulations depending on the different priming approaches. When they are developed for more HCV antigens, these strategies could be beneficial in therapeutic vaccine approaches.
- Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity(Wiley-Blackwell, 2007) Riezu-Boj, J.I. (José Ignacio); Whelan, M. (Myke); Paranhos-Baccala, G. (Glaucia); Staib, C. (Caroline); Berland, J.L. (Jean-Luc); Bartosch, B. (Birke); Larrea, E. (Esther); Rollier, C.S. (Christine S.); Pape, G.R. (Gerd R.); Sutter, G. (Gerd); Fagrouch, Z. (Zahra); Verschoor, E.J. (Ernst J.); Duverger, B. (Blandine); Diepolder, H.M. (Helmut M.); Meyr, M. (Marcus); Cosset, F. L. (Francoise-L.); Verstrepen, B.E. (Babs E.); Komurian-Pradel, F. (Florence); Himoudi, N. (Nourredine); Spaan, W.J.M. (Willy J.M.); Adams, V.A. (Victoria A.); Whelan, J.A. (Joseph A.); Heeney, J.L. (Jonathan L.); Drexhage, J.A.R. (Joost A.R.); Inchauspe, G. (Geneviese); Lasarte, J.J. (Juan José)Broad T cell and B cell responses to multiple HCV antigens are observed early in individuals who control or clear HCV infection. The prevailing hypothesis has been that similar immune responses induced by prophylactic immunization would reduce acute virus replication and protect exposed individuals from chronic infection. Here, we demonstrate that immunization of naïve chimpanzees with a multicomponent HCV vaccine induced robust HCV-specific immune responses, and that all vaccinees exposed to heterologous chimpanzee-adapted HCV 1b J4 significantly reduced viral RNA in serum by 84%, and in liver by 99% as compared to controls (P=0.024 and 0.028, respectively). However, despite control of HCV in plasma and liver in the acute period, in the chronic phase, 3 of 4 vaccinated animals developed persistent infection. Analysis of expression levels of proinflammatory cytokines in serial hepatic biopsies failed to reveal an association with vaccine outcome. However, expression of IDO, CTLA-4 [corrected] and PD-1 levels in liver correlated with clearance or chronicity. CONCLUSION: Despite early control of virus load, a virus-associated tolerogenic-like state can develop in certain individuals independent of vaccination history.